BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8182540)

  • 1. Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
    King GR; Ellinwood EH; Silvia C; Joyner CM; Xue Z; Caron MG; Lee TH
    J Pharmacol Exp Ther; 1994 May; 269(2):743-9. PubMed ID: 8182540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and serotonin release-regulating autoreceptor sensitivity in A9/A10 cell body and terminal areas after withdrawal of rats from continuous infusion of cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1445-53. PubMed ID: 8263807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranigral administration of D2 dopamine receptor antisense oligodeoxynucleotides establishes a role for nigrostriatal D2 autoreceptors in the motor actions of cocaine.
    Silvia CP; King GR; Lee TH; Xue ZY; Caron MG; Ellinwood EH
    Mol Pharmacol; 1994 Jul; 46(1):51-7. PubMed ID: 8058056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of continuous cocaine dose, treatment, and withdrawal duration on the induction of behavioral tolerance and dopamine autoreceptor function.
    King GR; Hillburn C; Pinto G; Konen J
    Pharmacol Biochem Behav; 2004 Jun; 78(2):293-300. PubMed ID: 15219770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes in sensitivity to apomorphine and monoamine receptors following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Synapse; 1994 Jan; 16(1):1-10. PubMed ID: 8134896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active versus passive cocaine administration: differences in the neuroadaptive changes in the brain dopaminergic system.
    Stefański R; Ziółkowska B; Kuśmider M; Mierzejewski P; Wyszogrodzka E; Kołomańska P; Dziedzicka-Wasylewska M; Przewłocki R; Kostowski W
    Brain Res; 2007 Jul; 1157():1-10. PubMed ID: 17544385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
    Strömberg I; Kehr J; Andbjer B; Fuxe K
    Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of SCH 23390 on the apomorphine subsensitivity in the substantia nigra and ventral tegmental area 1 day following withdrawal from continuous or intermittent cocaine pretreatment.
    Lee TH; Gao WY; Ellinwood EH
    Brain Res; 1997 Jan; 744(2):293-301. PubMed ID: 9027389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]dopamine and [3H]serotonin release in vitro induced by electrical stimulation in A9 and A10 dopamine regions of rat brain: characterization and responsiveness to cocaine.
    Chen NH; Reith ME
    J Pharmacol Exp Ther; 1993 Oct; 267(1):379-89. PubMed ID: 8229765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in behavior and central monoaminergic systems in the rat after repeated methamphetamine pretreatment: presynaptic regulatory mechanism].
    Ichikawa J
    Yakubutsu Seishin Kodo; 1988 Sep; 8(3):389-403. PubMed ID: 3250152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization to cocaine in the nigrostriatal dopamine system.
    Zahniser NR; Peris J; Dwoskin LP; Curella P; Yasuda RP; O'Keefe L; Boyson SJ
    NIDA Res Monogr; 1988; 88():55-77. PubMed ID: 3145458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to nicotine produces an increase in dopamine D2(High) receptors: a possible mechanism for dopamine hypersensitivity.
    Novak G; Seeman P; Le Foll B
    Int J Neurosci; 2010 Nov; 120(11):691-7. PubMed ID: 20942582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
    Joyce JN
    Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intrastriatal infusion of D2 receptor antisense oligonucleotide on apomorphine-induced behaviors in the rat.
    Rajakumar N; Laurier L; Niznik HB; Stoessl AJ
    Synapse; 1997 Jul; 26(3):199-208. PubMed ID: 9183809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of selective D1- or D2-like dopamine receptor antagonists with acute "binge" pattern cocaine on corticotropin-releasing hormone and proopiomelanocortin mRNA levels in the hypothalamus.
    Zhou Y; Spangler R; Yuferov VP; Schlussmann SD; Ho A; Kreek MJ
    Brain Res Mol Brain Res; 2004 Nov; 130(1-2):61-7. PubMed ID: 15519677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
    Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
    Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.